Cancer antigen 125 is associated with disease status in uterine carcinosarcoma

Uterine carcinosarcoma is a rare and aggressive tumor with poor outcomes. Cancer antigen 125 is routinely used to track the disease course of ovarian cancer and has been suggested as a biomarker in other aggressive forms of uterine cancer. We sought to characterize cancer antigen 125 as a potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Malcolm Strachan, Chandler, Chelsea Kilpatrick, Matsuo, Koji, Vargo, John Austin, Elishaev, Esther, Siripong, Nalyn, Berger, Jessica Layne, Kelley, Joseph Leo, Taylor, Sarah Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843728/
https://www.ncbi.nlm.nih.gov/pubmed/31741727
http://dx.doi.org/10.1177/2036361319884159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843728/
https://www.ncbi.nlm.nih.gov/pubmed/31741727
http://dx.doi.org/10.1177/2036361319884159

Ejemplares similares